While there are many treatment options for cancer patients, cancer remains the 2nd leading cause of death in the U.S. This is largely due to the development of drug resistant tumors which no longer respond to available treatment options.
Recognizing The Problem
Developing A Solution
The researchers at Chemosense have developed a powerful new therapy that prevents the development of chemotherapy resistance and also resensitizes tumors that have already become chemoresistant. Furthermore, this new therapy synergizes with existing chemotherapeutics, reducing the dosage of chemotherapy needed which in turn reduces the side effects commonly seen with these therapies.
Chemosense is committed to bringing our new therapy to market and making is available to patients that so desperately need it. Promising results from pre-clinical studies make it a strong candidate for further testing in clinical trials.